The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism
Patrick A. Vigueira, Kyle S. McCommis, Wesley T. Hodges, George G. Schweitzer, Serena L. Cole, Lalita Oonthonpan, Eric B. Taylor, William G. McDonald, Rolf F. Kletzien, Jerry R. Colca, Brian N. Finck
Dive into the research topics of 'The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism'. Together they form a unique fingerprint.